The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
Calcium signaling and molecular mechanisms underlying neurodegenerative diseases
Open accessAbstract
Calcium (Ca2+) is a ubiquitous second messenger that regulates various activities in eukaryotic cells. Especially important role calcium plays in excitable cells. Neurons require extremely precise spatial-temporal control of calcium-dependent processes because they regulate such vital functions as synaptic plasticity. Recent evidence indicates that neuronal calcium signaling is abnormal in many of neurodegenerative disorders such as Alzheimer’s disease (AD), Huntington’s disease (HD) and Parkinson’s disease (PD). These diseases represent a major medical, social, financial and scientific problem, but despite enormous research efforts, they are still incurable and only symptomatic relief drugs are available. Thus, new approaches and targets are needed. This review highlight neuronal calcium-signaling abnormalities in these diseases, with particular emphasis on the role of neuronal store-operated Ca2+ entry (SOCE) pathway and its potential relevance as a therapeutic target for treatment of neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calcium's Role in Mechanotransduction during Muscle Development
Benavides Damm, T., & Egli, M. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000356667 · Cited by 14,502
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Clapham, D. E. (2007) · Cell · doi:10.1016/j.cell.2007.11.028 · Cited by 4,175
Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055
Karran, E., Mercken, M., & Strooper, B. D. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3505 · Cited by 2,188 · cited 1×
“However, so far these agents did not show benefit in AD clinical trials (Cummings et al., 2014; Karran and Hardy, 2014; Karran et al., 2011).”
BackgroundBerridge, M. J. (1998) · Neuron · doi:10.1016/s0896-6273(00)80510-3 · Cited by 2,188
Store-Operated Calcium Channels
Parekh, A. B., & Putney, J. W. (2005) · Physiological Reviews · doi:10.1152/physrev.00057.2003 · Cited by 2,089
Lees, A. J., Hardy, J., & Revesz, T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60492-x · Cited by 1,956
Alzheimer’s disease drug-development pipeline: Few candidates, frequent failures
Cummings, J. L., Morstorf, T., & Zhong, K. (2014) · Alzheimer's Research & Therapy · doi:10.1186/alzrt269 · Cited by 1,744
Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
Hardingham, G. E., & Bading, H. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2911 · Cited by 1,644 · cited 1×
“Activation of synaptic NMDARs is required for synaptic plasticity and drives LTP generation, but sustained activation of NMDARs can cause subsequent calcium overload and toxicity (Hardingham and Bading, 2010).”
BackgroundBates, G. P., Dorsey, R., Gusella, J. F., Hayden, M. R., Kay, C., Leavitt, B. R., Nance, M., Ross, C. A., Scahill, R. I., Wetzel, R., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.5 · Cited by 1,641
Regulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561 · cited 2×
“Another adverse effect of Aβ is a reduction in NMDAR expression and its enhanced endocytosis (Snyder et al., 2005).”
G. Vonsattel, J. P., & DiFiglia, M. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199805000-00001 · Cited by 1,306
Lacor, P. N., Buniel, M. C., Furlow, P. W., Sanz Clemente, A., Velasco, P. T., Wood, M., Viola, K. L., & Klein, W. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3501-06.2007 · Cited by 1,188
Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease
Bezprozvanny, I., & Mattson, M. P. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.06.005 · Cited by 938
Self-citationArispe, N., Rojas, E., & Pollard, H. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.567 · Cited by 926
Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond
Lipton, S. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1958 · Cited by 909
‘Rejuvenation’ protects neurons in mouse models of Parkinson’s disease
Chan, C. S., Guzman, J. N., Ilijic, E., Mercer, J. N., Rick, C., Tkatch, T., Meredith, G. E., & Surmeier, D. J. (2007) · Nature · doi:10.1038/nature05865 · Cited by 904
De Felice, F. G., Velasco, P. T., Lambert, M. P., Viola, K., Fernandez, S. J., Ferreira, S. T., & Klein, W. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607483200 · Cited by 882
Langbehn, D., Brinkman, R., Falush, D., Paulsen, J., Hayden, M., & on behalf of an International Huntington's Disease Collaborative Group (2004) · Clinical Genetics · doi:10.1111/j.1399-0004.2004.00241.x · Cited by 817
The amyloid hypothesis for Alzheimer’s disease: A critical reappraisal
Hardy, J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06181.x · Cited by 814
Neuronal calcium signaling: function and dysfunction
Brini, M., Calì, T., Ottolini, D., & Carafoli, E. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1550-7 · Cited by 748
STIM2 Is a Feedback Regulator that Stabilizes Basal Cytosolic and Endoplasmic Reticulum Ca2+ Levels
Brandman, O., Liou, J., Park, W. S., & Meyer, T. (2007) · Cell · doi:10.1016/j.cell.2007.11.039 · Cited by 698
STIM proteins: dynamic calcium signal transducers
Soboloff, J., Rothberg, B. S., Madesh, M., & Gill, D. L. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3414 · Cited by 659
Tu, H., Nelson, O., Bezprozvanny, A., Wang, Z., Lee, S.-F., Hao, Y.-H., Serneels, L., De Strooper, B., Yu, G., & Bezprozvanny, I. (2006) · Cell · doi:10.1016/j.cell.2006.06.059 · Cited by 616
Self-citationKuchibhotla, K. V., Goldman, S. T., Lattarulo, C. R., Wu, H.-Y., Hyman, B. T., & Bacskai, B. J. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.008 · Cited by 614
Zeron, M. M., Hansson, O., Chen, N., Wellington, C. L., Leavitt, B. R., Brundin, P., Hayden, M. R., & Raymond, L. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00615-3 · Cited by 595
Dantrolene – A review of its pharmacology, therapeutic use and new developments
Krause, T., Gerbershagen, M. U., Fiege, M., Weißhorn, R., & Wappler, F. (2004) · Anaesthesia · doi:10.1111/j.1365-2044.2004.03658.x · Cited by 577
Parkinson’s Disease: From Pathogenesis to Pharmacogenomics
Cacabelos, R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030551 · Cited by 555
Milnerwood, A. J., Gladding, C. M., Pouladi, M. A., Kaufman, A. M., Hines, R. M., Boyd, J. D., Ko, R. W. Y., Vasuta, O. C., Graham, R. K., Hayden, M. R., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.01.008 · Cited by 517
STIM1 heteromultimerizes TRPC channels to determine their function as store-operated channels
Yuan, J. P., Zeng, W., Huang, G. N., Worley, P. F., & Muallem, S. (2007) · Nature Cell Biology · doi:10.1038/ncb1590 · Cited by 502
Tang, T.-S., Tu, H., Chan, E. Y. W., Maximov, A., Wang, Z., Wellington, C. L., Hayden, M. R., & Bezprozvanny, I. (2003) · Neuron · doi:10.1016/s0896-6273(03)00366-0 · Cited by 481
Self-citationCalcium signaling and neurodegenerative diseases
Bezprozvanny, I. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.01.001 · Cited by 469
Self-citationAdvances in the genetics of Parkinson disease
Trinh, J., & Farrer, M. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.132 · Cited by 466
Drug development in Alzheimer’s disease: the path to 2025
Cummings, J., Aisen, P. S., DuBois, B., Frölich, L., Jack, C. R., Jones, R. W., Morris, J. C., Raskin, J., Dowsett, S. A., & Scheltens, P. (2016) · Alzheimer's Research & Therapy · doi:10.1186/s13195-016-0207-9 · Cited by 459
Cheung, K.-H., Shineman, D., Müller, M., Cárdenas, C., Mei, L., Yang, J., Tomita, T., Iwatsubo, T., Lee, V. M.-Y., & Foskett, J. K. (2008) · Neuron · doi:10.1016/j.neuron.2008.04.015 · Cited by 450
Okamoto, S.-I., Pouladi, M. A., Talantova, M., Yao, D., Xia, P., Ehrnhoefer, D. E., Zaidi, R., Clemente, A., Kaul, M., Graham, R. K., et al. (2009) · Nature Medicine · doi:10.1038/nm.2056 · Cited by 436
Huntingtin Interacting Proteins Are Genetic Modifiers of Neurodegeneration
Kaltenbach, L. S., Romero, E., Becklin, R. R., Chettier, R., Bell, R., Phansalkar, A., Strand, A., Torcassi, C., Savage, J., Hurlburt, A., et al. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030082 · Cited by 434
Robust Pacemaking in Substantia Nigra Dopaminergic Neurons
Guzman, J. N., Sánchez-Padilla, J., Chan, C. S., & Surmeier, D. J. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2519-09.2009 · Cited by 411
Disturbed Ca2+signaling and apoptosis of medium spiny neurons in Huntington's disease
Tang, T.-S., Slow, E., Lupu, V., Stavrovskaya, I. G., Sugimori, M., Llinás, R., Kristal, B. S., Hayden, M. R., & Bezprozvanny, I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409402102 · Cited by 360
Self-citationStutzmann, G. E., Smith, I., Caccamo, A., Oddo, S., LaFerla, F. M., & Parker, I. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0739-06.2006 · Cited by 329
Leissring, M. A., Akbari, Y., Fanger, C. M., Cahalan, M. D., Mattson, M. P., & LaFerla, F. M. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.149.4.793 · Cited by 328
Williams, R. T., Manji, S. S. M., Parker, N. J., HANCOCK, M. S., van Stekelenburg, L., Eid, J.-P., Senior, P. V., Kazenwadel, J., Shandala, T., Saint, R. B., et al. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3570673 · Cited by 325
Internal Ca2+ mobilization is altered in fibroblasts from patients with Alzheimer disease.
Ito, E., Oka, K., Etcheberrigaray, R., Nelson, T. J., McPhie, D. L., Tofel-Grehl, B., Gibson, G. E., & Alkon, D. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.534 · Cited by 321
Ueda, K., Shinohara, S., Yagami, T., Asakura, K., & Kawasaki, K. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68010265.x · Cited by 319
Puopolo, M., Raviola, E., & Bean, B. P. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4341-06.2007 · Cited by 319
Jacob, C. P., Koutsilieri, E., Bartl, J., Neuen-Jacob, E., Arzberger, T., Zander, N., Ravid, R., Roggendorf, W., Riederer, P., & Grünblatt, E. (2007) · Journal of Alzheimer's Disease · doi:10.3233/jad-2007-11113 · Cited by 317
Chan, S. L., Mayne, M., Holden, C. P., Geiger, J. D., & Mattson, M. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000040200 · Cited by 313
Presenilin-Mediated Modulation of Capacitative Calcium Entry
Yoo, A. S., Cheng, I., Chung, S., Grenfell, T. Z., Lee, H., Pack-Chung, E., Handler, M., Shen, J., Xia, W., Tesco, G., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)00066-0 · Cited by 312
Alzheimer's Association Calcium Hypothesis Workgroup, & Khachaturian, Z. S. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.12.006 · Cited by 311
SERCA pump activity is physiologically regulated by presenilin and regulates amyloid β production
Green, K. N., Demuro, A., Akbari, Y., Hitt, B. D., Smith, I. F., Parker, I., & LaFerla, F. M. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200706171 · Cited by 304
Liao, Y., Erxleben, C., Abramowitz, J., Flockerzi, V., Zhu, M. X., Armstrong, D. L., & Birnbaumer, L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712288105 · Cited by 294
Dysfunction of NMDA receptors in Alzheimer’s disease
Zhang, Y., Li, P., Feng, J., & Wu, M. (2016) · Neurological Sciences · doi:10.1007/s10072-016-2546-5 · Cited by 282 · cited 9×
“In case of hippocampus, TRPC6 and Orai2 were recently identified as SOCE-forming channels in hippocampal neurons (Zhang et al., 2016a).”
BackgroundInfluentialStutzmann, G. E., Caccamo, A., LaFerla, F. M., & Parker, I. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4386-03.2004 · Cited by 278
Karran, E., & Hardy, J. (2014) · Annals of Neurology · doi:10.1002/ana.24188 · Cited by 275
Sun, S., Zhang, H., Liu, J., Popugaeva, E., Xu, N.-J., Feske, S., White, C. L., & Bezprozvanny, I. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.019 · Cited by 272
Self-citationThe L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease
Ilijic, E., Guzman, J. N., & Surmeier, D. J. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.04.007 · Cited by 259
Pathologically activated therapeutics for neuroprotection
Lipton, S. A. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2229 · Cited by 257
La Rovere, R. M. L., Roest, G., Bultynck, G., & Parys, J. B. (2016) · Cell Calcium · doi:10.1016/j.ceca.2016.04.005 · Cited by 257
Oulès, B., Del Prete, D., Greco, B., Zhang, X., Lauritzen, I., Sevalle, J., Moreno, S., Paterlini-Bréchot, P., Trebak, M., Checler, F., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0875-12.2012 · Cited by 244
Amyloid beta peptides and glutamatergic synaptic dysregulation
Parameshwaran, K., Dhanasekaran, M., & Suppiramaniam, V. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.10.008 · Cited by 235
Liao, Y., Plummer, N. W., George, M. D., Abramowitz, J., Zhu, M. X., & Birnbaumer, L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813346106 · Cited by 234
Use of antihypertensives and the risk of Parkinson disease
Becker, C., Jick, S. S., & Meier, C. R. (2008) · Neurology · doi:10.1212/01.wnl.0000303818.38960.44 · Cited by 230
Familial Alzheimer disease–linked mutations specifically disrupt Ca2+ leak function of presenilin 1
Nelson, O., Tu, H., Lei, T., Bentahir, M., de Strooper, B., & Bezprozvanny, I. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30447 · Cited by 226
Self-citationAmyloid β peptide oligomers directly activate NMDA receptors
Texidó, L., Martín-Satué, M., Alberdi, E., Solsona, C., & Matute, C. (2011) · Cell Calcium · doi:10.1016/j.ceca.2011.02.001 · Cited by 225
Dysregulation of neuronal calcium homeostasis in Alzheimer's disease – A therapeutic opportunity?
Popugaeva, E., Pchitskaya, E., & Bezprozvanny, I. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.09.053 · Cited by 214
Self-citationNimmrich, V., Grimm, C., Draguhn, A., Barghorn, S., Lehmann, A., Schoemaker, H., Hillen, H., Gross, G., Ebert, U., & Bruehl, C. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4771-07.2008 · Cited by 210
Cheung, K.-H., Mei, L., Mak, D.-O. D., Hayashi, I., Iwatsubo, T., Kang, D. E., & Foskett, J. K. (2010) · Science Signaling · doi:10.1126/scisignal.2000818 · Cited by 209
Dysfunctional synapse in Alzheimer's disease – A focus on NMDA receptors
Mota, S. I., Ferreira, I. L., & Rego, A. C. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.013 · Cited by 206
Calcium and Parkinson's disease
Surmeier, D. J., Schumacker, P. T., Guzman, J. D., Ilijic, E., Yang, B., & Zampese, E. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.168 · Cited by 202
KHACHATURIAN, Z. S. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb12485.x · Cited by 198
Aβ ion channels. Prospects for treating Alzheimer's disease with Aβ channel blockers
Arispe, N., Diaz, J. C., & Simakova, O. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.03.014 · Cited by 193
The role of Ca2+ signaling in Parkinson's disease
Zaichick, S. V., McGrath, K. M., & Caraveo, G. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.028738 · Cited by 188
Leissring, M. A., Paul, B. A., Parker, I., Cotman, C. W., & LaFerla, F. M. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0721061.x · Cited by 187
Structure of a presenilin family intramembrane aspartate protease
Li, X., Dang, S., Yan, C., Gong, X., Wang, J., & Shi, Y. (2013) · Nature · doi:10.1038/nature11801 · Cited by 186
Ferreira, I. L., Bajouco, L. M., Mota, S. I., Auberson, Y. P., Oliveira, C. R., & Rego, A. C. (2012) · Cell Calcium · doi:10.1016/j.ceca.2011.11.008 · Cited by 185
Zhang, H., Wu, L., Pchitskaya, E., Zakharova, O., Saito, T., Saido, T., & Bezprozvanny, I. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.1034-15.2015 · Cited by 181
Self-citationSubtype‐Specific Enhancement of NMDA Receptor Currents by Mutant Huntingtin
Chen, N., Luo, T., Wellington, C., Metzler, M., McCutcheon, K., Hayden, M. R., & Raymond, L. A. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0721890.x · Cited by 180
Role of Presenilins in Neuronal Calcium Homeostasis
Zhang, H., Sun, S., Herreman, A., De Strooper, B., & Bezprozvanny, I. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1554-10.2010 · Cited by 179
Self-citationRegulation of neurogenesis by calcium signaling
Toth, A. B., Shum, A. K., & Prakriya, M. (2016) · Cell Calcium · doi:10.1016/j.ceca.2016.02.011 · Cited by 172
γ-secretases: from cell biology to therapeutic strategies
Bergmans, B. A., & De Strooper, B. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70332-1 · Cited by 170
Calcium signalling and Alzheimer's disease
Berridge, M. J. (2011) · Neurochemical Research · doi:10.1007/s11064-010-0371-4 · Cited by 167
Leissring, M. A., Paul, B. A., Parker, I., Cotman, C. W., & LaFerla, F. M. (1999) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1999.721061.x · Cited by 162
Goussakov, I., Miller, M. B., & Stutzmann, G. E. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2474-10.2010 · Cited by 160
Use of Calcium Channel Blockers and Parkinson’s Disease
Pasternak, B., Svanström, H., Nielsen, N. M., Fugger, L. H., Melbye, M., & Hviid, A. P. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kwr362 · Cited by 159
Wu, J., Shih, H.-P., Vigont, V. A., Hrdlicka, L., Diggins, L. T., Singh, C. M., Mahoney, M. B., Chesworth, R., Shapiro, G., Zimina, O. A., et al. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.04.012 · Cited by 145
Zhang, H., Sun, S., Wu, L., Pchitskaya, E. I., Zakharova, O. A., Tacer, K. F., & Борисович, Б. И. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1188-16.2016 · Cited by 142
Self-citationAltered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease
Bruno, A. M., Huang, J. Y., Bennett, D. A., Marr, R. A., Hastings, M. L., & Stutzmann, G. E. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.03.011 · Cited by 140
Stabilizing ER Ca2+ Channel Function as an Early Preventative Strategy for Alzheimer’s Disease
Chakroborty, S., Briggs, C. A., Miller, M. B., Goussakov, I. V., Schneider, C., Kim, J. S., Wicks, J. M., Richardson, J. C., Conklin, V., Cameransi, B. G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052056 · Cited by 138
Wu, J., Ryskamp, D. A., Liang, X., Egorova, P. A., Zakharova, O. A., Hung, G., & Борисович, Б. И. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1038-15.2016 · Cited by 138
Corticostriatal synaptic adaptations in Huntington's disease
Plotkin, J. L., & Surmeier, D. J. (2015) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2015.01.020 · Cited by 136
Leissring, M. A., Parker, I., & LaFerla, F. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.32535 · Cited by 135
STIM and ORAI proteins in the nervous system
Kraft, R. (2015) · Channels · doi:10.1080/19336950.2015.1071747 · Cited by 133
Fan, M., Fernandes, H., Zhang, L. Y. J., Hayden, M., & Raymond, L. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4356-06.2007 · Cited by 131
Calcium signaling in Parkinson’s disease
Calí, T., Ottolini, D., & Brini, M. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1866-0 · Cited by 124
Genetics of Parkinson’s Disease
Singleton, A., & Clarimón, J. (2007) · CRC Press eBooks · doi:10.3109/9781420019223-5 · Cited by 124
Physiological Phenotype and Vulnerability in Parkinson's DiseasePreprint
Surmeier, D. J., Guzmán, J. N., Sánchez, J. A., & Schumacker, P. T. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009290 · Cited by 123
Bollimuntha, S., Singh, B. B., Shaik, S., Sharma, S. K., & Ebadi, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407384200 · Cited by 120
Susceptibility to calcium dysregulation during brain aging
Kumar, A., Bodhinathan, K., & Foster, T. C. (2009) · Frontiers in Aging Neuroscience · doi:10.3389/neuro.24.002.2009 · Cited by 119
Chakroborty, S., Kim, J., Schneider, C., Jacobson, C., Molgo, J., & Stutzmann, G. E. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0936-12.2012 · Cited by 118
Dantrolene ameliorates cognitive decline and neuropathology in Alzheimer triple transgenic mice
Peng, J., Liang, G., Inan, S., Wu, Z. F., Joseph, D. J., Meng, Q., Peng, Y., Eckenhoff, M. F., & Wei, H. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.04.008 · Cited by 116
Dantrolene is neuroprotective in Huntington's disease transgenic mouse model
Chen, X., Wu, J., Lvovskaya, S., Herndon, E., Supnet, C. B., & Борисович, Б. И. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-81 · Cited by 107
SOCE in neurons: Signaling or just refilling?
Majewski, Ł., & Kuźnicki, J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.01.019 · Cited by 102
Mechanisms of Gene-Environment Interactions in Parkinson’s Disease
Fleming, S. M. (2017) · Current Environmental Health Reports · doi:10.1007/s40572-017-0143-2 · Cited by 101
Rybalchenko, V., Hwang, S., Rybalchenko, N., & Koulen, P. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.06.023 · Cited by 99
Impairment of PARK14-dependent Ca2+ signalling is a novel determinant of Parkinson’s disease
Zhou, Q., Yen, A., Rymarczyk, G., Asai, H., Trengrove, C., Aziz, N. M., Kirber, M. T., Mostoslavsky, G., Ikezu, T., Wolozin, B. L., et al. (2016) · Nature Communications · doi:10.1038/ncomms10332 · Cited by 99
A pilot study of the clinical efficacy and safety of memantine for Huntington's disease
Ondo, W. G., Mejia, N. I., & Hunter, C. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2006.08.005 · Cited by 98
Striatal synaptic dysfunction and altered calcium regulation in Huntington disease
Raymond, L. A. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.07.058 · Cited by 98
Contribution of TRPC1 and Orai1 to Ca2+ Entry Activated by Store Depletion
Cheng, K. T., Ong, H. L., Liu, X., & Ambudkar, I. S. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-0265-3_24 · Cited by 95
Lack of Evidence for Presenilins as Endoplasmic Reticulum Ca2+ Leak Channels
Shilling, D. J., Mak, D. D., Kang, D. E., & Foskett, J. K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.300491 · Cited by 95
Emerging pathways driving early synaptic pathology in Alzheimer's disease
Briggs, C. A., Chakroborty, S., & Stutzmann, G. E. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.09.088 · Cited by 95
Tang, T.-S., Guo, C., Wang, H., Chen, X., & Борисович, Б. И. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4411-08.2009 · Cited by 94
Foster, T. C., Kyritsopoulos, C., & Kumar, A. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.05.012 · Cited by 94
Zhao, X., Weisleder, N. L., Han, X., Pan, Z., Parness, J., Brotto, M. A. P., & Ma, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602306200 · Cited by 89
The synaptic maintenance problem: membrane recycling, Ca2+ homeostasis and late onset degeneration
Борисович, Б. И., & Hiesinger, P. R. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-23 · Cited by 89
Orai, STIM1 and iPLA2β: a view from a different perspective
Bolotina, V. M. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.154997 · Cited by 87
Tong, B. C.-K., Lee, C. S.-K., Cheng, W.-H., Lai, K.-O., Kevin Foskett, J., & Cheung, K.-H. (2016) · Science Signaling · doi:10.1126/scisignal.aaf1371 · Cited by 87
Bojarski, Ł., Pomorski, P., Szybińska, A., Drab, M., Skibinska-Kijek, A., Gruszczynska‐Biegala, J., & Kuźnicki, J. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.11.008 · Cited by 86
Sun, Y., Zhang, H., Selvaraj, S., Sukumaran, P., Lei, S., Birnbaumer, L., & Singh, B. B. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.3010-16.2017 · Cited by 86
STIM2 protects hippocampal mushroom spines from amyloid synaptotoxicity
Александровна, П. Е., Pchitskaya, E. I., Speshilova, A. B., Alexandrov, S., Zhang, H., Власова, О. Л., & Борисович, Б. И. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0034-7 · Cited by 84
Self-citationDau, A., Gladding, C. M., Sepers, M. D., & Raymond, L. A. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.11.013 · Cited by 83
Gladding, C. M., Sepers, M. D., Xu, J., Zhang, L. Y. J., Milnerwood, A. J., Lombroso, P. J., & Raymond, L. A. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds154 · Cited by 82
Genetics of Parkinson's Disease
Kumar, K. R., Djarmati-Westenberger, A., & Grünewald, A. (2011) · Seminars in Neurology · doi:10.1055/s-0031-1299782 · Cited by 80
Bandara, S., Malmersjö, S., & Meyer, T. (2013) · Science Signaling · doi:10.1126/scisignal.2003649 · Cited by 79
The role of ryanodine receptor type 3 in a mouse model of Alzheimer disease
Liu, J., Supnet, C. B., Sun, S., Zhang, H., Good, L. B., Александровна, П. Е., & Борисович, Б. И. (2014) · Channels · doi:10.4161/chan.27471 · Cited by 77
Zhang, H., Liu, J., Sun, S., Pchitskaya, E. I., Александровна, П. Е., & Борисович, Б. И. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142427 · Cited by 76
Self-citationSignificance of Brain Lesions in Parkinson Disease Dementia and Lewy Body Dementia
Jellinger, K. A. (2009) · Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences · doi:10.1159/000197890 · Cited by 74
Hayrapetyan, V. Y., Rybalchenko, V., Rybalchenko, N., & Koulen, P. (2008) · Cell Calcium · doi:10.1016/j.ceca.2008.03.004 · Cited by 74
Mutagenesis Mapping of the Presenilin 1 Calcium Leak Conductance Pore
Nelson, O., Supnet, C. B., Tolia, A., Horré, K., Strooper, B. D., & Борисович, Б. И. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.243063 · Cited by 68
Activation Mechanism for CRAC Current and Store-operated Ca2+ Entry
Csutora, P., Zarayskiy, V. V., Peter, K., Monje, F. J., Smani, T., Zakharov, S. I., Litvinov, D. Y., & Bolotina, V. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606504200 · Cited by 60
Sinnen, B. L., Bowen, A. B., Gibson, E. S., & Kennedy, M. J. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1603-16.2016 · Cited by 59
Wu, J., Tang, T.-S., & Борисович, Б. И. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.08.036 · Cited by 56
Selective loss of NMDA receptor NR1 subunit isoforms in Alzheimer's disease
Hynd, M. R., Scott, H. L., & Dodd, P. R. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2003.02330.x · Cited by 54
Crosstalk between huntingtin and syntaxin 1A regulates N-type calcium channels.
Swayne, L. A., Chen, L., Hameed, S., Barr, W., Charlesworth, E., Colicos, M. A., Zamponi, G., & Braun, J. (2005) · Molecular and cellular neurosciences · doi:10.1016/j.mcn.2005.07.016 · Cited by 52
Emerging (and converging) pathways in Parkinson's disease: keeping mitochondrial wellness
Cieri, D., Brini, M., & Calí, T. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.153 · Cited by 50
Reduced Risk of Parkinson’s Disease in Users of Calcium Channel Blockers: A Meta-Analysis
Gudala, K., Kanukula, R., & Bansal, D. (2015) · International Journal of Chronic Diseases · doi:10.1155/2015/697404 · Cited by 48
The Presenilin-2 Loop Peptide Perturbs Intracellular Ca2+ Homeostasis and Accelerates Apoptosis
Cai, C., Lin, P., Cheung, K., Li, N., Levchook, C., Pan, Z., Ferrante, C., Boulianne, G. L., Foskett, J. K., Danielpour, D., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512026200 · Cited by 46
Gladding, C. M., Fan, J., Zhang, L. Y. J., Wang, L., Xu, J., Li, E. H. Y., Lombroso, P. J., & Raymond, L. A. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12700 · Cited by 33
Advancing pharmacotherapy for treating Huntington’s disease: a review of the existing literature
Mason, S., & Barker, R. A. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2016.1109630 · Cited by 33
Extracellular Calcium Has Multiple Targets to Control Cell Proliferation
Capiod, T. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-26974-0_7 · Cited by 28
Botelho, E. P., Wang, E. Y., Chen, J., Holley, S. M., André, V. M., Cepeda, C., & Levine, M. S. (2014) · PLoS Currents · doi:10.1371/currents.hd.34957c4f8bd7cb1f5ec47381dfc811c3 · Cited by 18
Cited by
Mitochondrial Dysfunction and Oxidative Stress in Alzheimer’s Disease
Misrani, A., Tabassum, S., & Yang, L. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.617588 · Cited by 654
Mitochondria-lysosome contacts regulate mitochondrial Ca2+dynamics via lysosomal TRPML1
Peng, W., Wong, Y. C., & Krainc, D. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2003236117 · Cited by 336
Polyglutamine Repeats in Neurodegenerative Diseases
Lieberman, A. P., Shakkottai, V. G., & Albin, R. L. (2019) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012857 · Cited by 304
Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer’s Disease
Cioffi, F., Adam, R. H. I., & Broersen, K. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190863 · Cited by 204
Chakroborty, S., Hill, E. S., Christian, D. T., Helfrich, R., Riley, S., Schneider, C., Kapecki, N., Mustaly-Kalimi, S., Seiler, F. A., Peterson, D. A., et al. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0307-7 · Cited by 71
Metadata
- Authors
- Pchitskaya, E., Popugaeva, E., & Bezprozvanny, I.
- Venue
- Cell Calcium
- Publisher
- Elsevier BV
- Published
- 2018-03
- Volume
- 70
- Pages
- 87-94
- ISSN
- 0143-4160 (ISSN-L)
- OpenAlex
- W2727054874
- Cited by
- 349
- References
- 143
- FWCI
- 16.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.